Considering the established link between obesity and risk for many types of cancer, the observation that SCD1 deficiency protects mice against high-fat diet-induced obesity and hepatic steatosis [119] suggests that SCD1 inhibitors could serve the dual purpose of blunting tumor growth and preventing obesity and associated metabolic conditions. Here, SCD is linked to Hepatic steatosis.